HK1157190A1 - Isolated renal cells and uses thereof - Google Patents
Isolated renal cells and uses thereofInfo
- Publication number
- HK1157190A1 HK1157190A1 HK11111451.6A HK11111451A HK1157190A1 HK 1157190 A1 HK1157190 A1 HK 1157190A1 HK 11111451 A HK11111451 A HK 11111451A HK 1157190 A1 HK1157190 A1 HK 1157190A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- renal cells
- isolated renal
- methods
- cell populations
- isolated
- Prior art date
Links
- 102000003951 Erythropoietin Human genes 0.000 abstract 2
- 108090000394 Erythropoietin Proteins 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 abstract 2
- 229940105423 erythropoietin Drugs 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 abstract 2
- 238000012258 culturing Methods 0.000 abstract 1
- 210000003292 kidney cell Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0684—Cells of the urinary tract or kidneys
- C12N5/0686—Kidney cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/02—Atmosphere, e.g. low oxygen conditions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/14—Erythropoietin [EPO]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
- C12N2509/10—Mechanical dissociation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11403008P | 2008-11-12 | 2008-11-12 | |
US11402508P | 2008-11-12 | 2008-11-12 | |
US20105608P | 2008-12-05 | 2008-12-05 | |
US20130508P | 2008-12-08 | 2008-12-08 | |
US12131108P | 2008-12-10 | 2008-12-10 | |
PCT/US2009/006085 WO2010056328A1 (en) | 2008-11-12 | 2009-11-12 | Isolated renal cells and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1157190A1 true HK1157190A1 (en) | 2012-06-29 |
Family
ID=41625133
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK11111451.6A HK1157190A1 (en) | 2008-11-12 | 2011-10-25 | Isolated renal cells and uses thereof |
HK14110826A HK1197267A1 (en) | 2008-11-12 | 2014-10-29 | Isolated renal cells and uses thereof |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK14110826A HK1197267A1 (en) | 2008-11-12 | 2014-10-29 | Isolated renal cells and uses thereof |
Country Status (10)
Country | Link |
---|---|
US (5) | US8318484B2 (de) |
EP (3) | EP3388509A1 (de) |
JP (5) | JP5974233B2 (de) |
KR (4) | KR102357077B1 (de) |
CN (2) | CN102271692B (de) |
AU (5) | AU2009314552B2 (de) |
CA (1) | CA2743459A1 (de) |
HK (2) | HK1157190A1 (de) |
NZ (2) | NZ601862A (de) |
WO (1) | WO2010056328A1 (de) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2008262333B2 (en) | 2007-06-08 | 2014-07-17 | Wake Forest University Health Sciences | Selective cell therapy for the treatment of renal failure |
US10590391B2 (en) | 2007-06-08 | 2020-03-17 | Wake Forest University Health Sciences | Selective cell therapy for the treatment of renal failure |
CA2780320A1 (en) | 2009-11-12 | 2011-05-19 | Tengion, Inc. | Rational design of regenerative medicine products |
EP2569418B1 (de) * | 2010-05-12 | 2016-11-02 | RegenMed (Cayman) Ltd. | Bioaktive nierenzellen |
KR101913874B1 (ko) * | 2010-11-10 | 2018-10-31 | 인리젠 | 장기 확대를 위한 주사가능 제제 |
EP3425391A1 (de) | 2011-11-04 | 2019-01-09 | inRegen | Arzneimittelscreening- und -potenztests |
WO2014066699A1 (en) | 2012-10-24 | 2014-05-01 | Tengion, Inc. | Renal cell populations and uses thereof |
JP6509745B2 (ja) * | 2013-01-25 | 2019-05-08 | エックスセル・バイオサイエンシズ・インコーポレイテッド | 標的細胞の選択的富化のための方法、組成物、キット、及びシステム |
BR112015027996A8 (pt) | 2013-05-08 | 2017-09-26 | Regenmedtx Llc | Organoides compreendendo células renais isoladas e suas utilizações |
NZ741539A (en) | 2015-11-06 | 2024-03-22 | Ventana Med Syst Inc | Representative diagnostics |
CN109890397A (zh) * | 2016-07-29 | 2019-06-14 | 迪帕克.简 | 用于治疗慢性肾病的生物活性肾细胞 |
US11123372B2 (en) | 2016-07-29 | 2021-09-21 | Prokidney | Bioactive renal cells for the treatment of chronic kidney disease |
CN111182921A (zh) * | 2017-06-21 | 2020-05-19 | 蒂莫西.A.伯特伦 | 用于治疗肾疾病的免疫豁免的生物活性肾细胞 |
CN108251352B (zh) * | 2018-02-01 | 2021-07-06 | 伯仕利生物科技发展(盐城)有限公司 | 一种血管内皮干细胞的培养方法 |
WO2021177387A1 (ja) * | 2020-03-04 | 2021-09-10 | 株式会社メトセラ | エリスロポエチン産生能が亢進された線維芽細胞 |
WO2021176420A1 (en) | 2020-03-06 | 2021-09-10 | ReGenesys BVBA | Biocompatible scaffolds for culturing post natal progenitor cells |
CN112107600B (zh) * | 2020-10-26 | 2024-04-05 | 张哲� | 一种治疗色素沉着性疾病的纳米制剂及其制备方法 |
CN114703120B (zh) * | 2022-03-17 | 2024-02-02 | 上海纽仁生物医药科技有限公司 | 一种动物神经系统血管平滑肌细胞单细胞的分离方法 |
CN114507642B (zh) * | 2022-03-17 | 2024-02-02 | 上海纽仁生物医药科技有限公司 | 一种动物神经系统周细胞单细胞的分离方法 |
WO2024006918A2 (en) * | 2022-06-29 | 2024-01-04 | Prakash Narayan | Selected renal cell populations, characteristics and uses thereof |
Family Cites Families (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6045849B2 (ja) * | 1980-08-25 | 1985-10-12 | 林原 健 | ヒトエリトロポエチンの製造方法 |
US5863531A (en) * | 1986-04-18 | 1999-01-26 | Advanced Tissue Sciences, Inc. | In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework |
US5032508A (en) | 1988-09-08 | 1991-07-16 | Marrow-Tech, Inc. | Three-dimensional cell and tissue culture system |
US5266480A (en) * | 1986-04-18 | 1993-11-30 | Advanced Tissue Sciences, Inc. | Three-dimensional skin culture system |
US4769037A (en) * | 1986-10-28 | 1988-09-06 | Midcalf Robert J | Artificial replacement kidney implant and method of dialyzing blood |
GB8722854D0 (en) * | 1987-09-29 | 1987-11-04 | Hardy S M | Implantable artificial kidney |
US5085629A (en) * | 1988-10-06 | 1992-02-04 | Medical Engineering Corporation | Biodegradable stent |
CN1053698C (zh) | 1989-01-19 | 2000-06-21 | 南京大学 | 细胞培养生产促红细胞生成素的方法 |
DE69017820T2 (de) | 1989-04-25 | 1995-10-05 | Childrens Medical Center | Implantaten für grosse mengen von zellen auf polymerische matrizen. |
US4996154A (en) * | 1989-05-04 | 1991-02-26 | Millipore Corporation | Method for growing cellular tissue |
AU2900792A (en) | 1991-10-24 | 1993-05-21 | Children's Medical Center Corporation | Neomorphogenesis of urological structures in vivo from cell culture |
PT101031B (pt) * | 1991-11-05 | 2002-07-31 | Transkaryotic Therapies Inc | Processo para o fornecimento de proteinas por terapia genetica |
US5549674A (en) * | 1992-03-02 | 1996-08-27 | The Regents Of The University Of Michigan | Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo |
US5429938A (en) * | 1992-03-02 | 1995-07-04 | University Of Michigan | Methods and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules |
US6060270A (en) * | 1992-03-02 | 2000-05-09 | The University Of Michigan | Methods and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules |
US6410320B1 (en) * | 1992-03-02 | 2002-06-25 | The University Of Michigan | Method and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules |
US5545131A (en) * | 1994-04-28 | 1996-08-13 | White Eagle International Technologies, Lp | Artificial kidney |
US6673339B1 (en) * | 1996-09-05 | 2004-01-06 | Children's Medical Center Corporation | Prosthetic kidney and its use for treating kidney disease |
DE69727817T2 (de) * | 1996-09-05 | 2005-01-05 | Children's Medical Center Corp., Boston | Nierenprothese und ihre Verwendung zum Behandeln einer Nierenkrankheit |
US5952226A (en) * | 1996-11-05 | 1999-09-14 | Modex Therapeutiques | Hypoxia responsive EPO producing cells |
GB2335127B (en) * | 1996-12-19 | 2002-02-13 | Hyundai Electronics America | Video frame rendering engine |
US5854006A (en) * | 1997-03-28 | 1998-12-29 | The University Of Virginia | Gamma-glutamyl transpeptidase-specific antibody, prodrugs for the treatment of gamma-glutamyl transpeptidase-expressing tumors, and methods of administration thereof |
US6224893B1 (en) | 1997-04-11 | 2001-05-01 | Massachusetts Institute Of Technology | Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering |
JP2004155788A (ja) * | 1998-09-24 | 2004-06-03 | Tanabe Seiyaku Co Ltd | 腎疾患治療薬およびそのスクリーニング方法 |
US6777205B1 (en) * | 1998-11-06 | 2004-08-17 | Sterrenbeld Biotechnologie North America, Inc. | Host cells expressing recombinant human erythropoietin |
MXPA01011429A (es) * | 1999-05-11 | 2003-09-10 | Ortho Mcneil Pharm Inc | Modelado farmacocinetico y farmacodinamico de administracion de eritropoyetina. |
US20040167634A1 (en) * | 1999-05-26 | 2004-08-26 | Anthony Atala | Prosthetic kidney and its use for treating kidney disease |
AU3195700A (en) | 1999-05-27 | 2000-12-18 | Tanabe Seiyaku Co., Ltd. | Remedies for kidney diseases and method for screening the same |
KR100369788B1 (ko) | 1999-09-03 | 2003-01-29 | 동아제약 주식회사 | 재조합 인간 에리트로포이에틴의 제조방법 |
US6376244B1 (en) * | 1999-12-29 | 2002-04-23 | Children's Medical Center Corporation | Methods and compositions for organ decellularization |
US7326570B2 (en) * | 2000-06-16 | 2008-02-05 | The Regents Of The University Of California | Induction of tubular morphogenesis using pleiotrophin |
US6548081B2 (en) * | 2000-07-28 | 2003-04-15 | Anika Therapeutics, Inc. | Bioabsorbable composites of derivatized hyaluronic acid and other biodegradable, biocompatible polymers |
DK1355655T5 (da) * | 2000-10-30 | 2007-08-13 | Zymogenetics Inc | Præparater og fremgangsmåder til forbedring af nyrefunktion |
WO2002061053A1 (en) | 2001-01-31 | 2002-08-08 | The General Hospital Corporation | Renal stem cells and uses thereof |
JPWO2002101029A1 (ja) * | 2001-05-31 | 2004-09-24 | 旭化成株式会社 | 腎再生用細胞の分離濃縮方法 |
US6784154B2 (en) * | 2001-11-01 | 2004-08-31 | University Of Utah Research Foundation | Method of use of erythropoietin to treat ischemic acute renal failure |
EP2292278B1 (de) * | 2001-11-16 | 2013-04-24 | Children's Medical Center Corporation | Verbesserung der Funktion von Organen |
US20030180268A1 (en) * | 2002-02-05 | 2003-09-25 | Anthony Atala | Tissue engineered construct for supplementing or replacing a damaged organ |
EP1491187A4 (de) | 2002-03-22 | 2008-04-16 | Kissei Pharmaceutical | Präventives oder therapeutisches mittel gegen nierenerkrankungen |
CA2521979A1 (en) * | 2003-04-09 | 2004-10-28 | University Of Utah Research Foundation | Compositions and methods related to production of erythropoietin |
US20060153894A1 (en) | 2004-06-30 | 2006-07-13 | Ragae Ghabrial | Multi-compartment delivery system |
AU2006292203A1 (en) | 2005-09-21 | 2007-03-29 | Dask Technologies, Llc | Methods and compositions for organ and tissue functionality |
CN102389344B (zh) * | 2006-02-07 | 2015-12-16 | 脊柱赛特有限公司 | 采用机械应变使人皮肤成纤维细胞发生软骨形成分化的方法 |
JP5416415B2 (ja) | 2006-02-10 | 2014-02-12 | テンジオン, インコーポレイテッド | 臓器の再建および増強のための骨格 |
JPWO2007125916A1 (ja) | 2006-04-24 | 2009-09-10 | 株式会社ステムセル研究所 | 移植用臓器の調製方法 |
ES2432395T3 (es) * | 2006-10-12 | 2013-12-03 | Ethicon, Inc. | Células derivadas de riñon y metodo de uso en la reparación y regeneración tisular |
WO2008061213A2 (en) | 2006-11-16 | 2008-05-22 | Genentech, Inc. | Genetic variations associated with tumors |
US20110008347A1 (en) | 2006-12-01 | 2011-01-13 | Agency For Science ,Technology And Research | Cancer-related protein kinases |
US10590391B2 (en) * | 2007-06-08 | 2020-03-17 | Wake Forest University Health Sciences | Selective cell therapy for the treatment of renal failure |
AU2008262333B2 (en) | 2007-06-08 | 2014-07-17 | Wake Forest University Health Sciences | Selective cell therapy for the treatment of renal failure |
WO2010057015A1 (en) | 2008-11-14 | 2010-05-20 | Wake Forest University Health Sciences | Kidney structures and methods of forming the same |
JP5565607B2 (ja) | 2009-07-15 | 2014-08-06 | 国立大学法人 東京大学 | 敗血症又は多臓器不全の予後診断方法及び予後診断用キット |
-
2009
- 2009-11-12 CN CN200980153736.XA patent/CN102271692B/zh active Active
- 2009-11-12 JP JP2011535572A patent/JP5974233B2/ja active Active
- 2009-11-12 EP EP18160803.5A patent/EP3388509A1/de active Pending
- 2009-11-12 CA CA2743459A patent/CA2743459A1/en active Pending
- 2009-11-12 KR KR1020187024239A patent/KR102357077B1/ko active IP Right Grant
- 2009-11-12 KR KR1020207034633A patent/KR102428795B1/ko active IP Right Grant
- 2009-11-12 KR KR1020117013368A patent/KR101735125B1/ko active IP Right Grant
- 2009-11-12 NZ NZ601862A patent/NZ601862A/en unknown
- 2009-11-12 WO PCT/US2009/006085 patent/WO2010056328A1/en active Application Filing
- 2009-11-12 CN CN201410138382.4A patent/CN103937737B/zh active Active
- 2009-11-12 EP EP13170810.9A patent/EP2662440B1/de active Active
- 2009-11-12 US US12/617,721 patent/US8318484B2/en active Active
- 2009-11-12 KR KR1020177010506A patent/KR101893717B1/ko active IP Right Grant
- 2009-11-12 AU AU2009314552A patent/AU2009314552B2/en active Active
- 2009-11-12 NZ NZ593207A patent/NZ593207A/xx unknown
- 2009-11-12 EP EP09760352.6A patent/EP2358375B1/de active Active
-
2011
- 2011-10-25 HK HK11111451.6A patent/HK1157190A1/xx unknown
-
2012
- 2012-10-26 US US13/661,668 patent/US9192629B2/en active Active
-
2014
- 2014-10-29 HK HK14110826A patent/HK1197267A1/xx unknown
-
2015
- 2015-08-24 JP JP2015164808A patent/JP2016028578A/ja not_active Withdrawn
- 2015-11-18 US US14/945,283 patent/US10105392B2/en active Active
-
2017
- 2017-05-02 AU AU2017202897A patent/AU2017202897B2/en active Active
-
2018
- 2018-05-16 JP JP2018094325A patent/JP2018148909A/ja active Pending
- 2018-10-15 US US16/160,741 patent/US20190117695A1/en not_active Abandoned
-
2019
- 2019-03-27 AU AU2019202099A patent/AU2019202099B2/en active Active
-
2020
- 2020-09-24 AU AU2020239736A patent/AU2020239736B2/en active Active
-
2021
- 2021-03-25 JP JP2021051049A patent/JP2021100428A/ja active Pending
-
2023
- 2023-05-09 JP JP2023076983A patent/JP2023100876A/ja active Pending
- 2023-10-10 US US18/484,426 patent/US20240108657A1/en active Pending
-
2024
- 2024-05-08 AU AU2024203036A patent/AU2024203036A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1157190A1 (en) | Isolated renal cells and uses thereof | |
WO2010088633A3 (en) | Novel cell lines and methods | |
MX2011011402A (es) | Sistemas, metodos y composiciones para optimizar injertos enriquecidos con celulas y tejidos. | |
WO2010096588A3 (en) | Cell culture media containing combinations of proteins | |
WO2009055183A3 (en) | Novel dyes | |
WO2011133902A3 (en) | Cell culture medium comprising small peptides | |
NZ602201A (en) | A novel ethanologenic clostridium species, clostridium coskatii | |
MX2010006169A (es) | Enfoques moleculares para la optimizacion de la produccion de biocombustibles. | |
PL2174524T3 (pl) | Ponowny wybór komórki w systemie komunikacji bezprzewodowej | |
WO2008122027A3 (en) | Novel electrode | |
EP2264779A4 (de) | Solarzelle, solarzellenstrang und solarzellenmodul | |
WO2014015841A3 (zh) | 一种利用微藻高效生产虾青素的方法 | |
MX2009011956A (es) | Metodos para detectar contaminantes organicos en la pulpa y fibra. | |
WO2010111659A8 (en) | Tumor-initiating cells and methods for using same | |
WO2011056644A3 (en) | Anti-glp-1r antibodies and their uses | |
WO2008118392A3 (en) | Synthetic cell platforms and methods of use thereof | |
EP2786999A4 (de) | Verbindung auf sulfonatbasis, polymerelektrolytmembran damit und brennstoffzelle damit | |
WO2009049274A8 (en) | Microorganism engineered to produce isopropanol | |
EP2325896A4 (de) | Frontelektrode für eine solarzelle zur stromverlustminimierung und solarzelle damit | |
TN2010000270A1 (en) | Process for the production of algal biomass with a high lipid content | |
WO2009102569A3 (en) | Cell lines and methods for making and using them | |
BRPI0910122A2 (pt) | "método de produção de biomassa de levedura" | |
WO2015004403A3 (fr) | Procede de culture cellulaire decouple | |
WO2011059920A3 (en) | Methods of generating neural stem cells | |
EP2343361A4 (de) | Zellkulturkit, prüfverfahren und herstellungsverfahren für das zellkulturkit |